Comments on the study "Saxagliptin adjunctive therapy in patients with poorly controlled diabetes type 2 diabetes treated with insulin or insulin independent with metformin"
2012
Abstract
The study using saxagliptin in people with insufficient compensation for type 2 diabetes on insulin treatment provides an answer to the fundamental question of how to treat such patients.